Smith & Nephew plc(NYSE:SNN)

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include inte...
Website: http://www.smith-nephew.com
Founded: 1856
Full Time Employees: 17,500
Sector: Healthcare
Industry: Medical Devices
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
| Unit: USD | 2025-08-05 | 2025-03-10 | 2025-02-25 | 2024-08-01 | 2024-02-27 | 2023-08-03 | 2023-02-21 | 2021-02-18 | 2018-12-31 | 2018-07-26 | 2017-07-27 | 2017-02-09 | 2016-07-28 | 2016-02-04 | 2015-07-30 | 2015-02-05 | 2014-12-31 | 2014-10-30 | 2014-08-01 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
revenue | 2,961 | 5,810 | 2,827 | 5,549 | 2,734 | 5,215 | 4,560 | 2,440 | 2,336 | 4,669 | 2,328 | 4,634 | 2,272 | ||||||
yoy | -46.64% | 11.41% | -38.00% | 12.05% | 123.24% | -2.33% | -47.35% | 2.82% | |||||||||||
qoq | 105.52% | -49.05% | 102.96% | -47.57% | 14.36% | 4.45% | -49.97% | 100.56% | -49.76% | 103.96% | |||||||||
cost of goods sold | -870 | -1,764 | -853 | -1,730 | -836 | -1,540 | -1,396 | -653 | -603 | -1,272 | -632 | -1,143 | -566 | ||||||
gross profit | 2,091 | 4,046 | 1,974 | 3,819 | 1,898 | 3,675 | 3,164 | 1,787 | 1,733 | 3,397 | 1,696 | 3,491 | 1,706 | ||||||
yoy | -45.25% | 10.10% | -37.61% | 6.21% | 112.06% | -6.86% | -48.81% | 1.58% | |||||||||||
qoq | 104.96% | -48.31% | 101.21% | -48.35% | 16.15% | 3.12% | -48.98% | 100.29% | -51.42% | 104.63% | |||||||||
gross margin % | 70.62% | NaN% | 69.64% | 69.83% | 68.82% | 69.42% | 70.47% | 69.39% | NaN% | 73.24% | 74.19% | 72.76% | 72.85% | 75.33% | 75.09% | NaN% | NaN% | NaN% | NaN% |
selling, general and administrative expenses | -1,519 | -3,100 | -1,509 | -3,055 | -1,457 | -2,880 | -2,562 | -1,299 | -1,212 | -2,366 | -1,226 | -2,641 | -1,157 | ||||||
research and development expenses | -143 | -289 | -137 | -339 | -166 | -345 | -307 | -116 | -107 | -230 | -113 | -222 | -110 | ||||||
operating profit | 429 | 657 | 328 | 425 | 275 | 450 | 295 | 372 | 414 | 801 | 357 | 628 | 439 | ||||||
yoy | 0.94% | 46.00% | 11.19% | -26.08% | 8.70% | -63.17% | -40.76% | -5.69% | |||||||||||
qoq | 100.30% | -22.82% | 54.55% | -38.89% | 52.54% | -10.14% | -48.31% | 124.37% | -43.15% | 43.05% | |||||||||
operating margin % | 14.49% | NaN% | 11.31% | 11.60% | 7.66% | 10.06% | 8.63% | 6.47% | NaN% | 15.25% | 17.72% | 17.16% | 15.34% | 13.55% | 19.32% | NaN% | NaN% | NaN% | NaN% |
interest income | 15 | 24 | 9 | 34 | 18 | 14 | 6 | 4 | 3 | ||||||||||
interest expense | -69 | -145 | -70 | -132 | -62 | -80 | -62 | -29 | -28 | ||||||||||
other finance costs | -12 | -28 | -12 | -6 | -16 | -6 | -15 | -7 | |||||||||||
share of results of associates | -10 | -30 | -20 | -141 | 14 | 2 | |||||||||||||
profit before taxation | 362 | 498 | 253 | 290 | 211 | 235 | 246 | 341 | 383 | 1,062 | 327 | 559 | 411 | ||||||
taxation | -69 | -86 | -39 | -27 | -39 | -12 | 202 | -67 | -59 | -278 | -86 | -149 | -116 | ||||||
attributable profit for the perioda | 293 | ||||||||||||||||||
earnings per ordinary sharea | |||||||||||||||||||
basic | 33.5 | 47.2 | |||||||||||||||||
diluted | 33.3 | 47 | |||||||||||||||||
attributable profit for the yeara | 412 | ||||||||||||||||||
| |||||||||||||||||||
attributable profita | 214 | 263 | 172 | 223 | 448 | 274 | 324 | 241 | |||||||||||
earnings per sharea | |||||||||||||||||||
basic | 24.5 | 30.2 | 19.7 | 25.5 | 51.3 | 31.4 | 37 | 88.1 | 27 | 45.9 | 33 | ||||||||
diluted | 24.5 | 30.1 | 19.7 | 25.5 | 51.2 | 31.2 | 37 | 87.8 | 26.9 | 45.6 | 32.8 | ||||||||
gain on disposal of interest in associate | |||||||||||||||||||
share of result from associates | |||||||||||||||||||
interest receivable | 6 | 2 | 11 | 7 | |||||||||||||||
interest payable | -52 | -26 | -49 | -25 | |||||||||||||||
share of losses from associates | -3 | -16 | -3 | ||||||||||||||||
profit on disposal of business | 326 | ||||||||||||||||||
attributable profit a | 784 | 410 | 295 | ||||||||||||||||
earnings per share a | |||||||||||||||||||
basic | 24.5 | 30.2 | 19.7 | 25.5 | 51.3 | 31.4 | 37 | 88.1 | 27 | 45.9 | 33 | ||||||||
diluted | 24.5 | 30.1 | 19.7 | 25.5 | 51.2 | 31.2 | 37 | 87.8 | 26.9 | 45.6 | 32.8 | ||||||||
m | |||||||||||||||||||
1,175 | 4,617 | ||||||||||||||||||
(293 | -1,162 | ||||||||||||||||||
882 | 3,455 | ||||||||||||||||||
(585 | -2,471 | ||||||||||||||||||
(62 | -235 | ||||||||||||||||||
235 | 749 | ||||||||||||||||||
4 | 13 | 4 | |||||||||||||||||
(3 | -35 | -0.5 | -2 | -8 | |||||||||||||||
(4 | -11 | ||||||||||||||||||
— | -2 | ||||||||||||||||||
232 | 714 | ||||||||||||||||||
(70 | -213 | ||||||||||||||||||
162 | 501 | ||||||||||||||||||
18.1 | 56.1 | ||||||||||||||||||
18.0 | 55.7 | ||||||||||||||||||
1,027 | 287 | 1,148 | |||||||||||||||||
(260 | -74.25 | -297 | |||||||||||||||||
767 | 212.75 | 851 | |||||||||||||||||
(528 | -158.5 | -634 | |||||||||||||||||
(59 | -14.25 | -57 | -39 | ||||||||||||||||
180 | 40 | 160 | |||||||||||||||||
3 | 1 | 4 | |||||||||||||||||
(2 | -2.25 | -9 | -2 | ||||||||||||||||
178 | 38.25 | 153 | |||||||||||||||||
(56 | -12.75 | -51 | |||||||||||||||||
122 | 25.5 | 102 | |||||||||||||||||
13.6 | 2.85 | 11.4 | |||||||||||||||||
13.5 | 2.825 | 11.3 | |||||||||||||||||
3 months | 3 | ||||||||||||||||||
2013 | 2,014 | ||||||||||||||||||
(26 | -6.5 | -19 | |||||||||||||||||
5 | 1.25 | -1 | |||||||||||||||||
(21 | -5.25 | -20 | |||||||||||||||||
71 | 17.75 | -127 | |||||||||||||||||
68 | 17 | -114 | |||||||||||||||||
47 | 11.75 | -134 | |||||||||||||||||
169 | 42.25 | -32 | |||||||||||||||||
1,074 | 1,147 | ||||||||||||||||||
(278 | -288 | ||||||||||||||||||
796 | 859 | ||||||||||||||||||
(550 | -661 | ||||||||||||||||||
(58 | -64 | ||||||||||||||||||
188 | 134 | ||||||||||||||||||
1 | |||||||||||||||||||
129 | 89 | ||||||||||||||||||
14.3 | 10 | ||||||||||||||||||
14.2 | 9.9 |
Balance Sheets:
Quarterly
Annual
| Unit: USD | 2025-08-05 | 2024-03-10 | 2024-02-25 | 2022-12-31 | 2021-12-31 | 2019-12-31 | 2018-12-31 | 2018-02-08 | 2016-12-31 | 2016-07-28 | 2014-12-31 | 2014-10-30 | 2014-08-01 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
assets | |||||||||||||
non-current assets | |||||||||||||
property, plant and equipment | 1,436 | 1,422 | 1,455 | 1,049 | 982 | 946 | 891 | 894 | 893 | ||||
goodwill | 3,111 | 3,026 | 3,031 | 2,371 | 2,188 | 2,227 | 2,027 | 2,024 | 2,070 | ||||
intangible assets | 962 | 1,032 | 1,236 | 1,371 | 1,411 | 1,535 | 1,747 | 1,812 | 1,868 | ||||
investments | 29 | 9 | 12 | 7,092 | 7,092 | 21 | 25 | 13 | 5 | 2 | 2 | ||
investments in associates | 7 | 7 | 46 | 112 | 112 | ||||||||
other non-current assets | 49 | 24 | 12 | 1,435 | 16 | ||||||||
retirement benefit assets | 70 | 63 | 141 | 62 | 5 | ||||||||
deferred tax assets | 401 | 350 | 177 | 127 | 97 | 110 | 77 | 90 | 84 | ||||
current assets | 3,077 | ||||||||||||
inventories | 2,467 | 2,387 | 2,205 | 1,304 | 1,244 | 1,291 | 1,181 | 1,209 | 1,185 | ||||
trade and other receivables | 1,435 | 1,381 | 1,264 | 1,258 | 1,185 | 1,166 | 1,166 | 1,173 | 1,207 | ||||
current tax receivable | 49 | 34 | 37 | ||||||||||
cash and cash equivalents | 676 | 619 | |||||||||||
total assets | 10,692 | 10,354 | 9,966 | 8,059 | 7,866 | 7,344 | 7,502 | 7,306 | 7,650 | 7,742 | |||
equity and liabilities | |||||||||||||
equity attributable to owners of the company | |||||||||||||
share capital | 175 | 175 | 175 | 177 | 177 | 178 | 180 | 182 | 184 | 184 | 184 | ||
share premium | 615 | 615 | 615 | 614 | 610 | 605 | 600 | 595 | 574 | 566 | 559 | ||
capital redemption reserve | 20 | 20 | 20 | 18 | 18 | 17 | 15 | 13 | 11 | 11 | 10 | ||
treasury shares | -48 | -66 | -118 | -120 | -189 | -257 | -432 | -283 | -321 | -320 | |||
other reserves | -347 | -497 | -459 | -228 | -375 | -280 | 18 | 132 | |||||
retained earnings | 5,121 | 5,018 | 5,026 | 4,329 | 3,970 | 3,717 | 3,650 | 3,559 | 3,590 | ||||
total equity | 5,536 | 5,265 | 5,259 | 4,874 | 4,644 | 3,958 | 3,944 | 4,040 | 4,017 | 4,155 | |||
non-current liabilities | 1,720 | ||||||||||||
long-term borrowings and lease liabilities | 3,297 | 3,258 | 2,712 | ||||||||||
retirement benefit obligations | 86 | 79 | 70 | 131 | 164 | 230 | 233 | 181 | 190 | ||||
other payables | 96 | 95 | 90 | 128 | 82 | 44 | |||||||
provisions | 94 | 95 | 84 | 97 | 134 | 143 | 63 | 64 | 71 | ||||
deferred tax liabilities | 42 | 31 | 36 | 97 | 94 | 38 | 98 | 170 | 169 | ||||
current liabilities | 1,465 | ||||||||||||
bank overdrafts, borrowings, loans and lease liabilities | 157 | 63 | 160 | ||||||||||
trade and other payables | 1,097 | 1,128 | 1,098 | 957 | 884 | 94 | 838 | 54 | 23 | ||||
current tax payable | 229 | 232 | 214 | 233 | 231 | 277 | 218 | 176 | 165 | ||||
total liabilities | 5,156 | 5,089 | 4,707 | 3,185 | 3,222 | 3,386 | 3,558 | 3,266 | 3,633 | 3,587 | |||
total equity and liabilities | 10,692 | 10,354 | 9,966 | 7,866 | 7,344 | 7,502 | 7,306 | 7,650 | 7,742 | ||||
non-current assets - sum | 6,110 | 4,950 | 5,121 | 5,210 | |||||||||
cash at bank | 350 | 1,142 | 163 | 169 | 100 | 85 | 93 | 147 | 140 | ||||
current assets - sum | 3,856 | 2,542 | 2,529 | 2,532 | |||||||||
non-current liabilities - sum | 2,992 | 2,213 | 2,405 | 2,439 | |||||||||
current liabilities - sum | 1,715 | 1,345 | 1,228 | 1,148 | |||||||||
| 3,994 | ||||||||||||
fixed assets | |||||||||||||
debtors | 2,852 | 2,265 | |||||||||||
creditors: amounts falling due within one year | |||||||||||||
borrowings | -432 | -1,851 | |||||||||||
other creditors | -949 | -2,543 | |||||||||||
net current assets | 2,613 | ||||||||||||
total assets less current liabilities | 9,705 | 6,972 | |||||||||||
creditors: amounts falling due after one year | |||||||||||||
total assets less total liabilities | 6,998 | 5,121 | |||||||||||
equity shareholders’ funds | |||||||||||||
capital reserve | 2,266 | 2,266 | |||||||||||
exchange reserve | -52 | -52 | |||||||||||
profit and loss account | 4,095 | 2,291 | |||||||||||
shareholders’ funds | 6,998 | 5,121 | |||||||||||
net current liabilities | -120 | ||||||||||||
consolidated balance sheet | |||||||||||||
goodwill and intangible assets | 3,547 | ||||||||||||
total liabilities and equity | 8,059 | ||||||||||||
net debt3 | 1,104 | ||||||||||||
investment in associates | 118 | 114 | 112 | 109 | |||||||||
equity attributable to equity holders of the parent | |||||||||||||
long-term borrowings | 1,423 | 1,564 | 1,708 | 1,666 | 1,936 | 1,986 | |||||||
bank overdrafts and loans | 27 | 86 | 71 | 39 | 91 | 65 | |||||||
revenue | 4,669 | ||||||||||||
cost of goods sold | -1,272 | ||||||||||||
gross profit | 3,397 | ||||||||||||
selling, general and administrative expenses | -2,366 | ||||||||||||
research and development expenses | -230 | ||||||||||||
operating profit | 801 | ||||||||||||
interest income | 6 | ||||||||||||
interest expense | -52 | ||||||||||||
other finance costs | -16 | ||||||||||||
share of results of associates | -3 | ||||||||||||
profit on disposal of business | 326 | ||||||||||||
profit before taxation | 1,062 | ||||||||||||
taxation | -278 | ||||||||||||
attributable profit for the year1 | 784 | ||||||||||||
earnings per ordinary share1 | |||||||||||||
basic | 88.1 | ||||||||||||
diluted | 87.8 | ||||||||||||
group statement of comprehensive income | |||||||||||||
other comprehensive income: | |||||||||||||
items that will not be reclassified to income statement | |||||||||||||
re-measurement of net retirement benefit obligations | -81 | ||||||||||||
taxation on other comprehensive income | 10 | ||||||||||||
total items that will not be reclassified to income statement | -71 | ||||||||||||
items that may be reclassified subsequently to income statement | |||||||||||||
cash flow hedges – interest rate derivatives | |||||||||||||
– losses arising in the year | |||||||||||||
cash flow hedges – forward foreign exchange contracts | |||||||||||||
– gains/losses) arising in the year | -15 | ||||||||||||
– losses transferred to inventories for the year | 20 | ||||||||||||
fair value remeasurement of available for sale asset | 10 | ||||||||||||
exchange differences on translation of foreign operations | -134 | ||||||||||||
total items that may be reclassified subsequently to income statement | -119 | ||||||||||||
other comprehensive expense for the year, net of taxation | -190 | ||||||||||||
total comprehensive income for the year1 | 594 | ||||||||||||
retirement benefit asset | 7 | ||||||||||||
assets held for sale | 10 | ||||||||||||
non-current assets: | |||||||||||||
loans to associates | 187 | 184 | |||||||||||
non-current assets: - sum | 4,866 | ||||||||||||
current assets: | |||||||||||||
current assets: - sum | 2,440 | ||||||||||||
equity attributable to owners of the company: | |||||||||||||
non-current liabilities: | |||||||||||||
non-current liabilities: - sum | 2,104 | ||||||||||||
current liabilities: | |||||||||||||
current liabilities: - sum | 1,162 |
Cashflow Statements:
Quarterly
Annual
| Unit: USD | |
|---|---|
cash flows from operating activities | |
profit before taxation | |
net interest payable/ | |
depreciation, amortisation and impairment | |
loss on disposal of property, plant and equipment and software | |
distribution from investment | |
share-based payments expense | |
share of results of associates | |
dividends received from associates | |
profit on disposal of manufacturing facility | |
profit on disposal of net assets held for sale | |
net movement in post retirement benefit obligations | |
(increase)/decrease in inventories | |
increase in trade and other receivables | |
increase in trade and other payables and provisions | |
cash generated from operations | |
interest received | |
interest paid | |
income taxes paid | |
net cash inflow from operating activities | |
cash flows from investing activities | |
acquisitions, net of cash acquired | |
proceeds on disposal of net assets held for sale | |
capital expenditure | |
investment in associate | |
purchase of investments | |
proceeds from associate loan redemption | |
proceeds on disposal of manufacturing facility | |
cash received on disposal of associate | |
net cash from investing activities | |
cash flows from financing activities | |
proceeds from issue of ordinary share capital | |
purchase of own shares | |
proceeds of borrowings due within one year | |
settlement of borrowings due within one year | |
proceeds on borrowings due after one year | |
settlement of borrowings due after one year | |
proceeds from own shares | |
settlement of currency swaps | |
equity dividends paid | |
net cash from/(used in) financing activities | |
net (decrease)/increase in cash and cash equivalents | |
cash and cash equivalents at beginning of year | |
exchange adjustments | |
cash and cash equivalents at end of year |
